Filiz Hazan
Filiz Hazan has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
- Semra Gürsoy
Department of Pediatric Genetics Dokuz Eylül University Faculty of Medicine Izmir Turkey
10 shared publications - Behzat Özkan
Department of Pediatric Endocrinology, University of Health Sciences, İzmir Faculty of Medicine, Dr. Behçet Uz Pediatric Diseases and Surgery Training and Research Hospital, İzmir, Turkey
8 shared publications - Özlem Nalbantoğlu
Department of Pediatric Endocrinology, University of Health Sciences, İzmir Faculty of Medicine, Dr. Behçet Uz Children’s Hospital, İzmir, Türkiye
6 shared publications - Hüseyin Anıl Korkmaz
University of Health Sciences, İzmir Faculty of Medicine, Dr. Behçet Uz Children’s Hospital
4 shared publications - Tarık Kırkgöz
Department of Pediatrics, Division of Endocrinology, University of Health Sciences, Kayseri City Hospital, Kayseri, Türkiye
4 shared publications - Sezer Acar
Division of Pediatric Endocrinology, Dr. Behçet Uz Children’s Education and Research Hospital, Izmir, Turkey
3 shared publications
Latest Publications
- 6 November 2026
- Published by Springer Nature in Journal of Human Genetics
- p. 1-10
Expanding mutational landscape and clinical phenotype of the CASK-related neurological disorders
CASK-related disorders comprise two main phenotypes: severe microcephaly with pontocerebellar hypoplasia (MICPCH), typically caused by truncating variants, and milder X-linked intellectual disability (XLID), usually associated with missense variants. We aimed to characterize this molecular spectrum within an underrepresented national cohort. We evaluated 18 affected individuals from 16 unrelated families with CASK variants identified through exome or genome sequencing. Clinical, neurodevelopmental and neuroimaging findings were systematically reviewed. Selected missense variants were evaluated by in silico prediction tools and structural modeling. We identified 16 distinct CASK variants, 11 of which are novel, including frameshift, stop-gain, splice-site, and missense variants, as well as one large deletion. Consistent with known genotype-phenotype correlations, null alleles resulted in the severe MICPCH phenotype, while presumed hypomorphic alleles were associated with XLID. However, unlike previous reports, our MICPCH patients exhibited a higher frequency of dysmorphic facial features (86%), skeletal anomalies (57%) and sensorineural hearing loss (43%). Furthermore, contrary to the literature suggesting a milder epilepsy in females due to X-inactivation, 63% of our female patients with MICPCH presented with recurrent seizures. This cohort broadens both the molecular and phenotypic spectrum of CASK-related disorders. Findings reinforce that truncating variants predominantly cause MICPCH, while missense variants can lead to various outcomes depending on domain-level structural impact. We demonstrate that the CASK phenotypic spectrum is broader than previously recognized, frequently involving distinctive facial dysmorphism, skeletal defects and hearing impairment, suggesting that CASK plays a critical role not only in synaptic function but also in wider developmental processes.
- 6 November 2026
- Published by Springer Nature in Journal of Human Genetics
- p. 1-10
Expanding mutational landscape and clinical phenotype of the CASK-related neurological disorders
CASK-related disorders comprise two main phenotypes: severe microcephaly with pontocerebellar hypoplasia (MICPCH), typically caused by truncating variants, and milder X-linked intellectual disability (XLID), usually associated with missense variants. We aimed to characterize this molecular spectrum within an underrepresented national cohort. We evaluated 18 affected individuals from 16 unrelated families with CASK variants identified through exome or genome sequencing. Clinical, neurodevelopmental and neuroimaging findings were systematically reviewed. Selected missense variants were evaluated by in silico prediction tools and structural modeling. We identified 16 distinct CASK variants, 11 of which are novel, including frameshift, stop-gain, splice-site, and missense variants, as well as one large deletion. Consistent with known genotype-phenotype correlations, null alleles resulted in the severe MICPCH phenotype, while presumed hypomorphic alleles were associated with XLID. However, unlike previous reports, our MICPCH patients exhibited a higher frequency of dysmorphic facial features (86%), skeletal anomalies (57%) and sensorineural hearing loss (43%). Furthermore, contrary to the literature suggesting a milder epilepsy in females due to X-inactivation, 63% of our female patients with MICPCH presented with recurrent seizures. This cohort broadens both the molecular and phenotypic spectrum of CASK-related disorders. Findings reinforce that truncating variants predominantly cause MICPCH, while missense variants can lead to various outcomes depending on domain-level structural impact. We demonstrate that the CASK phenotypic spectrum is broader than previously recognized, frequently involving distinctive facial dysmorphism, skeletal defects and hearing impairment, suggesting that CASK plays a critical role not only in synaptic function but also in wider developmental processes.
- 2 October 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (10) , 833
Clinical spectrum and genetic landscape of MTHFR deficiency: a cohort study including novel variants
- 2 October 2026
- Published by Springer Nature in Neurological Sciences
- Vol. 47 (10) , 833
Clinical spectrum and genetic landscape of MTHFR deficiency: a cohort study including novel variants
- 24 August 2026
- Published by Elsevier in Archives de Pédiatrie
- Vol. 33 (7)
Clinical and molecular characterization of 5α-reductase deficiency type 2: First report of a family with homozygous deletion in exon 1 of SRD5A2
- 24 August 2026
- Published by Elsevier in Archives de Pédiatrie
- Vol. 33 (7)
Clinical and molecular characterization of 5α-reductase deficiency type 2: First report of a family with homozygous deletion in exon 1 of SRD5A2
- 4 July 2026
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- Vol. 45 (4) , 353-362
Retrovesical Hybrid Benign Peripheral Nerve Sheath Tumor with a Heterozygous Germline NF2 Deletion in a 12-Year-Old Boy: A Case Report
Hybrid benign peripheral nerve sheath tumors (BPNSTs) are a relatively recently recognized group of nerve sheath neoplasms composed of variable proportions of schwannomatous, neurofibromatous, and/...
- 4 July 2026
- Published by Taylor & Francis in Fetal and Pediatric Pathology
- Vol. 45 (4) , 353-362
Retrovesical Hybrid Benign Peripheral Nerve Sheath Tumor with a Heterozygous Germline NF2 Deletion in a 12-Year-Old Boy: A Case Report
Hybrid benign peripheral nerve sheath tumors (BPNSTs) are a relatively recently recognized group of nerve sheath neoplasms composed of variable proportions of schwannomatous, neurofibromatous, and/...
- 12 May 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (6) , 573-581
Genetic evaluation of a group of patients with transient congenital hypothyroidism by targeted exome sequencing
Objectives: Transient congenital hypothyroidism (TCH) is characterized by congenital hypothyroidism (CH) which spontaneously resolves in the first years of life. While most cases are sporadic, several studies from worldwide showed variants in DUOX2 , DUOXA2, TSHR genes in the etiology of TCH. The aim of our study is to evaluate the genetic etiology of TCH. Methods: A total of 54 patients from 50 families with TCH were included the study. The age at diagnosis, age at time of drug discontinuation, gender, consanguinity, the presence of additional examination findings, venous fT4 and TSH levels at the time of diagnosis, at time of drug discontinuation and at the last visit, the follow-up data and genetic characteristics were obtained from records. Results: A total of 54 patients from 50 families [59.3 % male (n=32) and 40.7 % female (n=22)] with TCH were included in the study. Pathogenic variants were detected in 15 out of 54 patients. 10 different DUOX2 variants (c.1060C>T, c.1547G>A, c.2597T>G, c.3314T>C, c.3382C>A, c.3509A>C, c.3790A>G, c.4445C>T, c.28del, c.533G>T) were identified in 11 patients (2 homozygous, 3 compound heterozygous, and 6 heterozygous). Conclusions: Our findings suggest that DUOX2 variants are the main genetic cause of TCH. We reported novel variants in the DUOX2 and TSHR genes that expand their mutational spectrum. These findings support the need for incorporating molecular analysis into the diagnostic evaluation of TCH, not only to improve our knowledge of its genetic underly, but also to provide valuable insights for long-term follow-up, family counseling, and personalized management strategies.
- 12 May 2026
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (6) , 573-581
Genetic evaluation of a group of patients with transient congenital hypothyroidism by targeted exome sequencing
Objectives: Transient congenital hypothyroidism (TCH) is characterized by congenital hypothyroidism (CH) which spontaneously resolves in the first years of life. While most cases are sporadic, several studies from worldwide showed variants in DUOX2 , DUOXA2, TSHR genes in the etiology of TCH. The aim of our study is to evaluate the genetic etiology of TCH. Methods: A total of 54 patients from 50 families with TCH were included the study. The age at diagnosis, age at time of drug discontinuation, gender, consanguinity, the presence of additional examination findings, venous fT4 and TSH levels at the time of diagnosis, at time of drug discontinuation and at the last visit, the follow-up data and genetic characteristics were obtained from records. Results: A total of 54 patients from 50 families [59.3 % male (n=32) and 40.7 % female (n=22)] with TCH were included in the study. Pathogenic variants were detected in 15 out of 54 patients. 10 different DUOX2 variants (c.1060C>T, c.1547G>A, c.2597T>G, c.3314T>C, c.3382C>A, c.3509A>C, c.3790A>G, c.4445C>T, c.28del, c.533G>T) were identified in 11 patients (2 homozygous, 3 compound heterozygous, and 6 heterozygous). Conclusions: Our findings suggest that DUOX2 variants are the main genetic cause of TCH. We reported novel variants in the DUOX2 and TSHR genes that expand their mutational spectrum. These findings support the need for incorporating molecular analysis into the diagnostic evaluation of TCH, not only to improve our knowledge of its genetic underly, but also to provide valuable insights for long-term follow-up, family counseling, and personalized management strategies.
- Open Access
- 4 February 2026
- Published by Pediatric Practice and Research Journal in Pediatric Practice and Research
- Vol. 14 (1) , 11833482
TRACK Syndrome Caused by Homozygous TSEN2 c.1100-5T>A Variant Presenting with Atypical Hemolytic Uremic Syndrome and Early End-Stage Kidney Disease
Background: TRACK syndrome, first described by Canpolat et al., is a rare disorder caused by splice-site mutations in TSEN2, characterized by craniofacial malformations, central nervous system (CNS) anomalies, progressive kidney disease. Case Presentation: We present a 2.5-year-old boy, third child of consanguineous parents, admitted with fever and cough, diagnosed with atypical hemolytic uremic syndrome (aHUS). Whole exome sequencing revealed a homozygous intronic TSEN2 variant (c.1100-5T>A), consistent with TRACK syndrome. Two deceased siblings had similar dysmorphic features and early-onset renal failure. The proband exhibited microcephaly, craniofacial dysmorphism, left atrial dilation, and laboratory findings consistent with thrombotic microangiopathy (TMA). Despite pathogenic TSEN2 variant, he’d normal intellectual and motor development. He’s currently 6 years old, undergoing peritoneal dialysis, receiving biweekly eculizumab, and antiepileptic therapy. Conclusion: This report highlights a rare cause of aHUS and end-stage kidney disease (ESKD) due to a TSEN2 splice-site mutation, further expanding the phenotypic spectrum of TRACK syndrome.
- 4 February 2026
- Published by Pediatric Practice and Research Journal in Pediatric Practice and Research
- Vol. 14 (1) , 11833482
Open AccessTRACK Syndrome Caused by Homozygous TSEN2 c.1100-5T>A Variant Presenting with Atypical Hemolytic Uremic Syndrome and Early End-Stage Kidney Disease
Background: TRACK syndrome, first described by Canpolat et al., is a rare disorder caused by splice-site mutations in TSEN2, characterized by craniofacial malformations, central nervous system (CNS) anomalies, progressive kidney disease. Case Presentation: We present a 2.5-year-old boy, third child of consanguineous parents, admitted with fever and cough, diagnosed with atypical hemolytic uremic syndrome (aHUS). Whole exome sequencing revealed a homozygous intronic TSEN2 variant (c.1100-5T>A), consistent with TRACK syndrome. Two deceased siblings had similar dysmorphic features and early-onset renal failure. The proband exhibited microcephaly, craniofacial dysmorphism, left atrial dilation, and laboratory findings consistent with thrombotic microangiopathy (TMA). Despite pathogenic TSEN2 variant, he’d normal intellectual and motor development. He’s currently 6 years old, undergoing peritoneal dialysis, receiving biweekly eculizumab, and antiepileptic therapy. Conclusion: This report highlights a rare cause of aHUS and end-stage kidney disease (ESKD) due to a TSEN2 splice-site mutation, further expanding the phenotypic spectrum of TRACK syndrome.
- Open Access
- 12 November 2025
- Published by Springer Nature in BMC Immunology
- Vol. 26 (1) , 1-13
Expanding the clinical spectrum of Cernunnos/XLF deficiency: a literature review of a rare cause of severe combined immunodeficiency including a novel case
Severe combined immunodeficiency (SCID) is a congenital immunodeficiency characterized by significant numerical or functional defects in T lymphocytes and is often accompanied by B lymphocyte dysfunction. It presents early in life with severe, recurrent opportunistic infections. Early diagnosis and hematopoietic stem cell transplantation (HSCT) are vital for patient survival. Cernunnos/XLF deficiency is an autosomal recessive form of SCID caused by mutations in the NHEJ1 gene, which plays a critical role in repairing DNA double-strand breaks. First described in 2006, this condition remains exceedingly rare, with only about 55 cases reported to date. This study aimed to describe a novel infant with Cernunnos/XLF deficiency and to review previously reported patients carrying the same variant, thereby expanding the clinical spectrum of this rare disease. With written informed consent, we retrospectively evaluated a pediatric patient with Cernunnos/XLF deficiency followed at our clinic. Demographic, clinical, laboratory, and radiological findings were reviewed. The diagnosis was based on clinical and immunological features and confirmed via clinical exome sequencing. A literature review was conducted to compare the genotype–phenotype correlations of previously reported patients carrying the same NHEJ1 variant. We report an infant who was hospitalized at 6.5 months of age with a preliminary diagnosis of meningitis and was subsequently diagnosed with Cernunnos/XLF deficiency. The patient exhibited microcephaly, growth retardation, recurrent infections, prolonged SARS-CoV-2 PCR positivity, and localized BCGitis following live Bacillus Calmette–Guérin (BCG) vaccination. Immunological evaluation revealed T- and B-cell lymphopenia and hypogammaglobulinemia. Genetic testing confirmed a homozygous nonsense mutation in NHEJ1. HSCT from a matched sibling donor was performed. This study describes a rare case of Cernunnos/XLF deficiency diagnosed in early infancy, underscoring the value of early recognition and the critical role of genetic testing and HSCT. It also expands the clinical spectrum of the disease and provides a comparative perspective with previously reported patients carrying the same mutation. In infants presenting with unexplained infections or complications related to live vaccines, inborn errors of immunity should be considered. Our findings emphasize the importance of timely diagnosis and comprehensive, multidisciplinary follow-up, particularly in patients with additional complications.
- 12 November 2025
- Published by Springer Nature in BMC Immunology
- Vol. 26 (1) , 1-13
Open AccessExpanding the clinical spectrum of Cernunnos/XLF deficiency: a literature review of a rare cause of severe combined immunodeficiency including a novel case
Severe combined immunodeficiency (SCID) is a congenital immunodeficiency characterized by significant numerical or functional defects in T lymphocytes and is often accompanied by B lymphocyte dysfunction. It presents early in life with severe, recurrent opportunistic infections. Early diagnosis and hematopoietic stem cell transplantation (HSCT) are vital for patient survival. Cernunnos/XLF deficiency is an autosomal recessive form of SCID caused by mutations in the NHEJ1 gene, which plays a critical role in repairing DNA double-strand breaks. First described in 2006, this condition remains exceedingly rare, with only about 55 cases reported to date. This study aimed to describe a novel infant with Cernunnos/XLF deficiency and to review previously reported patients carrying the same variant, thereby expanding the clinical spectrum of this rare disease. With written informed consent, we retrospectively evaluated a pediatric patient with Cernunnos/XLF deficiency followed at our clinic. Demographic, clinical, laboratory, and radiological findings were reviewed. The diagnosis was based on clinical and immunological features and confirmed via clinical exome sequencing. A literature review was conducted to compare the genotype–phenotype correlations of previously reported patients carrying the same NHEJ1 variant. We report an infant who was hospitalized at 6.5 months of age with a preliminary diagnosis of meningitis and was subsequently diagnosed with Cernunnos/XLF deficiency. The patient exhibited microcephaly, growth retardation, recurrent infections, prolonged SARS-CoV-2 PCR positivity, and localized BCGitis following live Bacillus Calmette–Guérin (BCG) vaccination. Immunological evaluation revealed T- and B-cell lymphopenia and hypogammaglobulinemia. Genetic testing confirmed a homozygous nonsense mutation in NHEJ1. HSCT from a matched sibling donor was performed. This study describes a rare case of Cernunnos/XLF deficiency diagnosed in early infancy, underscoring the value of early recognition and the critical role of genetic testing and HSCT. It also expands the clinical spectrum of the disease and provides a comparative perspective with previously reported patients carrying the same mutation. In infants presenting with unexplained infections or complications related to live vaccines, inborn errors of immunity should be considered. Our findings emphasize the importance of timely diagnosis and comprehensive, multidisciplinary follow-up, particularly in patients with additional complications.
- 29 January 2025
- Published by Elsevier in Pediatric Neurology
- Vol. 165, 43-51
The Clinical and Molecular Spectrum of Patients With X-Linked Intellectual Disability and Novel Variations in Different Genes
- 29 January 2025
- Published by Elsevier in Pediatric Neurology
- Vol. 165, 43-51
The Clinical and Molecular Spectrum of Patients With X-Linked Intellectual Disability and Novel Variations in Different Genes
- 20 September 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 37 (12) , 1104-1111
A rare case of skeletal dysplasia: biallelic variant in ACAN gene
Objectives: Spondylo-epimetaphyseal dysplasia-aggregan (SEMD-ACAN) is a rare form of osteo-chondrodysplasia that includes vertebral, epiphyseal and metaphyseal dysplasia. It occurs as a result of loss-of-function mutations in the ACAN gene, which encodes aggregan protein, which is the basic component of the extracellular matrix in cartilage. It results in disproportionately short stature and skeletal abnormalities. Here, we aimed to present the fourth SEMD-ACAN report in the literature. Case presentation: A 9-year-old girl was admitted to our clinic with growth retardation. She was born from a first-degree cousin marriage with severe short stature (41 cm; −3.54 SDS). Her mother also had severe short stature. Her height was 110 cm (−4.6 SDS); she had midface hypoplasia, low-set ears, short neck, short limbs, and central obesity. Biochemical and hormonal tests were normal. Skeletal survey showed moderate platyspondylia, thoracolumbar scoliosis, lumbar lordosis, bilateral femoro-acetabular narrowing, and advanced bone age (10 years). The patient’s brother was 100 cm (−3.97 SDS). He had similar but milder clinical findings. Biallelic ACAN variation (c.512C>T; p. Ala171Val) was detected in two siblings by next-generation sequencing. The parents were heterozygous carriers. Before, the heterozygous form of this variant has been reported in a 15-year-old boy with short stature, advanced bone age, and dysmorphic features. Conclusions: SEMD-ACAN is a rare genetic condition that affects bone growth and development and can cause physical and developmental abnormalities. This article highlights the importance of considering genetic testing in characteristic symptoms associated with SEMD-ACAN, such as severe growth retardation and skeletal abnormalities.
- 20 September 2024
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 37 (12) , 1104-1111
A rare case of skeletal dysplasia: biallelic variant in ACAN gene
Objectives: Spondylo-epimetaphyseal dysplasia-aggregan (SEMD-ACAN) is a rare form of osteo-chondrodysplasia that includes vertebral, epiphyseal and metaphyseal dysplasia. It occurs as a result of loss-of-function mutations in the ACAN gene, which encodes aggregan protein, which is the basic component of the extracellular matrix in cartilage. It results in disproportionately short stature and skeletal abnormalities. Here, we aimed to present the fourth SEMD-ACAN report in the literature. Case presentation: A 9-year-old girl was admitted to our clinic with growth retardation. She was born from a first-degree cousin marriage with severe short stature (41 cm; −3.54 SDS). Her mother also had severe short stature. Her height was 110 cm (−4.6 SDS); she had midface hypoplasia, low-set ears, short neck, short limbs, and central obesity. Biochemical and hormonal tests were normal. Skeletal survey showed moderate platyspondylia, thoracolumbar scoliosis, lumbar lordosis, bilateral femoro-acetabular narrowing, and advanced bone age (10 years). The patient’s brother was 100 cm (−3.97 SDS). He had similar but milder clinical findings. Biallelic ACAN variation (c.512C>T; p. Ala171Val) was detected in two siblings by next-generation sequencing. The parents were heterozygous carriers. Before, the heterozygous form of this variant has been reported in a 15-year-old boy with short stature, advanced bone age, and dysmorphic features. Conclusions: SEMD-ACAN is a rare genetic condition that affects bone growth and development and can cause physical and developmental abnormalities. This article highlights the importance of considering genetic testing in characteristic symptoms associated with SEMD-ACAN, such as severe growth retardation and skeletal abnormalities.
- Open Access
- 31 May 2024
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 8 (2) , 507-510
SCOT Deficiency Mimicking Sepsis: An Unusual Cause of Increased Anion Gap Metabolic Acidosis
Introduction: Succinyl-CoA:3-oxoacid CoA transferase (SCOT, EC 2.8.3.5) deficiency is a rare autosomal recessive inborn error of metabolism (IEM). We report here an infant admitted to intensive care unit with the diagnosis of sepsis. Case Presentation: A five-month-old female patient was admitted to the intensive care unit with lethargy and respiratory distress. She had severe high anion gap metabolic acidosis. The IEM was screened by plasma amino acid analysis, showing no abnormalities, and by acylcarnitine analysis, showing low-normal levels of free carnitine. Urine organic acid analysis revealed massive ketonuria and elevated levels of dicarboxylic acids. Fatty acid oxidation disorder-targeted gene panel revealed a homozygous splice site variant (c.78+1_78+6 del) in the OXCT1 gene. Discussion and Conclusion: SCOT deficiency should be considered when massive ketosis is detected in increased anion gap metabolic acidosis with sepsis-like manifestation. Supportive therapy should be initiated quickly to prevent irreversible neurological damage.
- 31 May 2024
- Published by Dokuz Eyul Universitesi Saglik Bilimleri Enstitusu in Journal of Basic and Clinical Health Sciences
- Vol. 8 (2) , 507-510
Open AccessSCOT Deficiency Mimicking Sepsis: An Unusual Cause of Increased Anion Gap Metabolic Acidosis
Introduction: Succinyl-CoA:3-oxoacid CoA transferase (SCOT, EC 2.8.3.5) deficiency is a rare autosomal recessive inborn error of metabolism (IEM). We report here an infant admitted to intensive care unit with the diagnosis of sepsis. Case Presentation: A five-month-old female patient was admitted to the intensive care unit with lethargy and respiratory distress. She had severe high anion gap metabolic acidosis. The IEM was screened by plasma amino acid analysis, showing no abnormalities, and by acylcarnitine analysis, showing low-normal levels of free carnitine. Urine organic acid analysis revealed massive ketonuria and elevated levels of dicarboxylic acids. Fatty acid oxidation disorder-targeted gene panel revealed a homozygous splice site variant (c.78+1_78+6 del) in the OXCT1 gene. Discussion and Conclusion: SCOT deficiency should be considered when massive ketosis is detected in increased anion gap metabolic acidosis with sepsis-like manifestation. Supportive therapy should be initiated quickly to prevent irreversible neurological damage.